Express Scripts Holding Company (ESRX) Rating Reiterated by Robert W. Baird
Express Scripts Holding Company (NASDAQ:ESRX)‘s stock had its “hold” rating reaffirmed by investment analysts at Robert W. Baird in a report issued on Friday. They currently have a $56.00 target price on the stock. Robert W. Baird’s price objective indicates a potential downside of 9.91% from the company’s previous close.
A number of other brokerages have also recently commented on ESRX. BidaskClub raised shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Needham & Company LLC assumed coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They set a “hold” rating on the stock. Cowen and Company reaffirmed an “outperform” rating and set a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the stock a “buy” rating in a research note on Tuesday, August 29th. Finally, ValuEngine cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Four research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $70.24.
Shares of Express Scripts Holding (ESRX) traded down 1.05% during trading on Friday, reaching $62.16. 2,458,504 shares of the company’s stock traded hands. The stock has a market cap of $35.90 billion, a P/E ratio of 10.79 and a beta of 0.88. The company has a 50 day moving average price of $61.87 and a 200-day moving average price of $63.73. Express Scripts Holding has a one year low of $57.80 and a one year high of $77.50.
Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business’s revenue was up .5% on a year-over-year basis. During the same quarter last year, the company earned $1.57 EPS. On average, equities research analysts expect that Express Scripts Holding will post $6.99 EPS for the current fiscal year.
In related news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.68% of the stock is currently owned by company insiders.
Several hedge funds have recently modified their holdings of ESRX. Burt Wealth Advisors increased its position in shares of Express Scripts Holding by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after purchasing an additional 174 shares during the last quarter. CKW Financial Group increased its position in shares of Express Scripts Holding by 20.0% during the 2nd quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after purchasing an additional 300 shares during the last quarter. Dubuque Bank & Trust Co. increased its position in shares of Express Scripts Holding by 53.1% during the 1st quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after purchasing an additional 608 shares during the last quarter. TrimTabs Asset Management LLC acquired a new stake in shares of Express Scripts Holding during the 1st quarter worth about $121,000. Finally, Capital Analysts LLC increased its position in shares of Express Scripts Holding by 5.6% during the 1st quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after purchasing an additional 100 shares during the last quarter. 88.70% of the stock is owned by hedge funds and other institutional investors.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.